LI-RADS categories: concepts, definitions, and criteria-Reference-Cited by-同舟云学术

LI-RADS categories: concepts, definitions, and criteria

Published:2017-10-16 Issue:1 Volume:43 Page:101-110
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Santillan Cynthia^ORCID,Chernyak Victoria,Sirlin Claude

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://link.springer.com/article/10.1007/s00261-017-1334-x/fulltext.html

Reference8 articles.

1. American College of Radiology (2017). Liver imaging reporting and data system version 2017. http://www.acr.org/Quality-Safety/Resources/LIRADS . Accessed date on August 2017

2. Kielar A, et al. (2017) Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). doi: 10.1007/s00261-017-1281-6

3. Choi SH, et al. (2016) Liver Imaging Reporting and Data System v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol 51(8):483–490

4. Cruite I, Tang A, Sirlin CB (2013) Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol 201(1):41–55

5. Wiesner RH, Freeman RB, Mulligan DC (2004) Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127(5 Suppl 1):S261–S267

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC;Abdominal Radiology;2024-06-11

2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

3. Based on Gadolinium Ethoxybenzyl DTPA–Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma;Technology in Cancer Research & Treatment;2024-01

4. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01

5. Imaging of Alcohol-Associated Liver Disease;American Journal of Roentgenology;2023-12-06